100% Quality Guarantee
PhD-Level Technical Support
Key Features

Human TLR8 (Toll Like Receptor 8) ELISA (Small Sample Volume) (AEKE06996)

SKU AEKE06996
Reactivity Human
Detection Method Sandwich
Sensitivity 0.112 ng/mL
Standard 20 ng/mL
Range 0.32-20 ng/mL
$857 - $7,710

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

Human TLR8 ELISA Kit (Small Sample Volume)

Human TLR8 ELISA kits are used to detect Toll Like Receptor 8 (TLR8) in serum, plasma, tissue homogenates and other biological samples. TLR8, or Toll-like receptor 8 (CD288), is an endosomal pattern recognition receptor expressed mainly in monocytes, macrophages and myeloid dendritic cells. It senses single-stranded RNA, in particular GU-rich RNA and degradation products of microbial RNA generated in the endolysosome, including RNA of viruses such as SARS-CoV-2 and HIV, and it signals through MyD88 to activate NF-kappa-B and IRF pathways, which drives production of pro-inflammatory cytokines and type I interferon. TLR8 therefore contributes to antiviral and antibacterial defence and to shaping adaptive immunity. Gain-of-function variants cause an X-linked immunodeficiency with autoinflammation, and TLR8 activity has also been linked to autoimmune disease, so it is a target for vaccine adjuvant and anti-inflammatory research.

system_update_altDatasheetsystem_update_altMSDS
View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose